Terminated × Biliary Tract Neoplasms × Gastrointestinal × Clear all Liver and Biliary Tumor Tissue Registry
Terminated
1,000 enrolled
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
Phase 1/2 Terminated
75 enrolled 17 charts
GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer
Phase 2 Terminated
10 enrolled
NIRADO
Phase 2 Terminated
51 enrolled
A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors
Phase 1/2 Terminated
175 enrolled
Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)
Phase 2 Terminated
15 enrolled 8 charts
A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors
Phase 1/2 Terminated
5 enrolled 9 charts
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
Terminated
14 enrolled
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Phase NA Terminated
54 enrolled
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Phase 1 Terminated
115 enrolled
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
Phase 1/2 Terminated
13 enrolled 24 charts
EQLVCPAL
Terminated
31 enrolled
FBI-TRAC
Phase 2 Terminated
13 enrolled
SOCABS
Phase NA Terminated
3 enrolled
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC
Phase 2/3 Terminated
309 enrolled 17 charts
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).
Phase 2 Terminated
2 enrolled 9 charts
TELE-ABC
Phase 2 Terminated
53 enrolled 47 charts
A Study of HA121-28 Tablets in Advanced Biliary Tract Cancer
Phase 2 Terminated
31 enrolled
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase 2 Terminated
30 enrolled
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer
Phase 1 Terminated
39 enrolled
Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC
Phase 1/2 Terminated
204 enrolled
BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer
Phase 1 Terminated
9 enrolled 12 charts
N1
Terminated
23 enrolled
A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Phase 1/2 Terminated
9 enrolled 7 charts
GTX Regimen for Biliary Cancers
Phase 2 Terminated
4 enrolled 7 charts
Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study
Phase 1 Terminated
6 enrolled 6 charts
A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma
Phase 2 Terminated
9 enrolled 7 charts
GetBil
Phase 2 Terminated
19 enrolled
Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer
Phase 2 Terminated
78 enrolled